CCL2 and obesity due to melanocortin 4 receptor deficiency: Further characterization of its role in obesity-related comorbidities may open the door for more targeted interventions including more focused exercise programs, nutraceutical or pharmacological interventions that modulate CCL2 levels to tackle inflammation in obesity.